STOCK TITAN

QTREX Quantum completes Global Inkjet Systems acquisition

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

QTREX Quantum Ltd. completed its acquisition of Global Inkjet Systems Limited (GIS) on November 16, 2026, acquiring all issued and outstanding GIS shares and rights to transaction intercompany debt and other debt transferred under the agreement. Consideration was entirely QTREX securities; base consideration, excluding the Additional Warrants, was valued at US$16 million based on $1.10 per Ordinary Share, subject to adjustment.

At a December 28, 2026 extraordinary meeting, shareholders of record as of November 25 will vote on issuing the Ordinary Shares underlying the Penny Warrants and Additional Warrants upon exercise. The board unanimously recommends approval, which requires at least a majority of votes cast at the meeting. The warrants cover up to 317,329 and 10,909,091 shares, respectively, at exercise prices of $0.0001 and $1.21 per share. If approval is not obtained by the 90th day after issuance, Nano may require redemption for $349,061.90 and $1 million, respectively; payment is due within three trading days after QTREX receives notice.

1 point · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Major pointGIS acquisition closed November 16, 2026; base consideration was valued at US$16 million. 20% of market cap

Negative

  • None.

Filing Explained

A failed vote leaves repeated meetings required; resale registration remains a best-efforts filing obligation.

Beyond the Penny and Additional Warrants awaiting the December 28, 2026 vote, the GIS consideration also included 3,551,693 ordinary shares, pre-funded warrants for up to 10,130,977 shares, and a separate holdback pre-funded warrant for up to 545,455 shares. The two pre-funded warrants are exercisable at $0.0001 per share; if exercised, their underlying shares would increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

The agreement requires a shareholder meeting within 45 days after closing; if approval fails, QTREX must hold another meeting within 90 days after the agreement and then continue meetings every 45 days until approval or termination of the warrants. The agreement also requires QTREX to use its best efforts to file a resale registration statement within 21 days after closing.

Base consideration US$16 million Excludes the Additional Warrants; subject to adjustment.
Base consideration per-share price $1.10 per Ordinary Share Price used to value the base consideration, subject to adjustment.
Penny Warrant underlying shares Up to 317,329 shares Issuance of the underlying shares is subject to shareholder approval.
Penny Warrant exercise price $0.0001 per Ordinary Share The aggregate exercise price was prepaid, except for this remaining nominal exercise price.
Additional Warrant underlying shares Up to 10,909,091 shares Issuance of the underlying shares is subject to shareholder approval.
Additional Warrant exercise price $1.21 per Ordinary Share Exercise price for the Additional Warrants.
Penny Warrant redemption amount $349,061.90 Nano may require cash redemption if approval is not obtained by the 90th day following issuance.
Additional Warrant redemption amount $1 million Nano may require cash redemption if approval is not obtained by the 90th day following issuance.
pre-funded warrants financial
"pre-funded warrants exercisable to purchase up to 10,130,977 Ordinary Shares"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
cashless basis technical
"it may be exercised on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
Simple Majority regulatory
"at least a majority of the votes cast by shareholders at the Meeting"
broker non-vote regulatory
"A “broker non-vote” occurs when a bank, broker or other holder"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
Nasdaq Listing Rule 5635(d) regulatory
"Under Nasdaq Listing Rule 5635(d), shareholder approval is required"
Nasdaq Listing Rule 5635(d) is a stock-exchange rule that determines when a company must get shareholder approval before issuing new shares tied to conversions or exercises of existing convertible securities, options or warrants. It matters to investors because it controls potential dilution of their holdings and changes in voting power—think of it like a rule that decides whether a previously agreed‑upon coupon can be redeemed without asking the group again.
End Date regulatory
"the 90th day following the issuance date of the Penny Warrants (the “End Date”)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QTEX shares are covered by the warrants in the shareholder vote?

The proposal covers up to 317,329 Penny Warrant shares and up to 10,909,091 Additional Warrant shares upon exercise. Their exercise prices are $0.0001 and $1.21 per Ordinary Share, respectively.

When are QTEX warrant redemptions payable if approval is missed?

After Nano gives a Redemption Notice, QTREX must pay within three trading days after receiving it. The possible redemption amounts are $349,061.90 for the Penny Warrants and $1 million for the Additional Warrants if approval is not obtained by the 90th day following issuance.

What does QTREX expect to gain from acquiring GIS?

The board believes the acquisition brings key production controls in-house and expands capacity to manufacture cryogenic interconnects at commercial scale. It expects GIS’s capabilities to support higher production throughput, improved consistency in radio-frequency performance, and development of additional interconnect materials and embedded passive components.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of November 2026 (Report No. 3)

 

Commission File Number: 001-40303

 

Qtrex Quantum Ltd.

(Translation of registrant’s name into English)

 

2 Ilan Ramon St.

Ness-Ziona 7403635, Israel

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

☒ Form 20-F      ☐ Form 40-F

 

 

 

 

 

 

CONTENTS

 

Attached hereto and incorporated herein is Qtrex Quantum Ltd.’s (the “Company”) Notice of Extraordinary General Meeting of Shareholders (the “Meeting”), Proxy Statement and Proxy Card for the Meeting to be held on December 28, 2026.

 

Only shareholders of record who hold ordinary shares, no par value, of the Company at the close of business on November 25, 2026, will be entitled to notice of and to vote at the Meeting and any postponements or adjournments thereof.

 

This Foreign Private Issuer Report on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308, 333-289324 and 333-296482) and Form S-8 (Registration Nos. 333-297590, 333-259057, 333-277980, 333-285565, 333-290162 and 333-292592), filed  with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

EXHIBIT INDEX

 

Exhibit
Number
  Description of Document
99.1   Notice of Meeting, Proxy Statement and Proxy Card for the Extraordinary General Meeting of Shareholders to be held on December 28, 2026.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Qtrex Quantum Ltd.
     
Date: November 20, 2026 By: /s/ Dagi Ben-Noon
    Name:  Dagi Ben-Noon
    Title: Chief Executive Officer

 

2

 

Exhibit 99.1

 

QTREX QUANTUM LTD.

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 

Notice is hereby given that an Extraordinary General Meeting of Shareholders (the “Meeting”) of QTREX Quantum Ltd. (“QTREX” or the “Company”) will be held on December 28, 2026, at 2:00 p.m. Israel time at the Company’s office, located at 2 Ilan Ramon St., Ness-Ziona, 7403635, Israel.

 

The Meeting is being called for the following purposes:

 

1.To approve the issuance of the Company’s ordinary shares underlying the Penny Warrants and the Additional Warrants, upon exercise thereof, each as defined in the accompanying proxy statement, exercisable to purchase the Company’s ordinary shares, no par value per share, as part of the consideration of the Share and Intercompany Debt Purchase Agreement between the Company and Nano Dimension Ltd., dated as of November 16, 2026, to acquire all of the issued and outstanding shares and intercompany debt of Global Inkjet Systems Limited (“Proposal 1”);

 

Board Recommendation

 

The Board unanimously recommends that you vote in favor of Proposal 1, as described in the accompanying proxy statement (the “Proxy Statement”).

 

Record Date

 

Shareholders of record at the close of business on November 25, 2026 (the “Record Date”), are entitled to notice of and to vote at the Meeting, either in person or by appointing a proxy to vote in their stead at the Meeting (as detailed below).

 

Required Vote and Voting Procedures

 

Pursuant to the Israeli Companies Law, 5759-1999 (the “Companies Law”), Proposal 1, as described below, requires the affirmative vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary Shares representing, in the aggregate, at least a majority of the votes cast by shareholders at the Meeting with respect to Proposal 1 (a “Simple Majority”).

 

How You Can Vote

 

A form of proxy for use at the Meeting is attached to the Proxy Statement, and together with a return envelope, will be sent to holders of the Company’s Ordinary Shares. By appointing “proxies,” shareholders may vote at the Meeting regardless of whether they attend in person. If a properly executed proxy in the attached form is received by the Company at least four (4) hours prior to the Meeting, all of the Ordinary Shares represented by the proxy shall be voted as indicated on the form. Subject to applicable law and the rules of the Nasdaq Stock Market, in the absence of instructions, the Ordinary Shares represented by properly executed and received proxies will be voted “FOR” Proposal 1, for which the Board recommends a vote “FOR”.

 

Shareholders may revoke their proxies or voting instruction form (as applicable) in accordance with Section 9 of the Companies Law regulations (proxy and position statements), by filing with the Company a written notice of revocation or duly executed proxy or voting instruction form (as applicable) bearing a later date and time.

 

Shareholders of Record

 

If your shares are registered directly in your name with our transfer agent, Equinity Trust Company LLC, you are considered, with respect to those shares, the shareholder of record. In such case, these proxy materials are being sent directly to you. As the shareholder of record, you have the right to use the proxy card included with this Proxy Statement to grant your voting proxy directly to Yafit Tehila, the Chief Financial Officer of the Company (yafit@q-trex.com), or to vote in person at the Meeting.

 

Beneficial Owners

 

If your shares are held through a bank, broker or other nominee, they are considered to be held in “street name” and you are the beneficial owner with respect to those shares. A beneficial owner as of the Record Date has the right to direct the bank, broker or nominee how to vote the shares held by such beneficial owner at the Meeting. If your shares are held in “street name,” as of the Record Date, these proxy materials will be forwarded to you by your bank, broker or nominee who is considered, with respect to those shares, as the shareholder of record, together with a voting instruction card for you to use in directing the bank, broker or nominee how to vote your shares. You also may attend the Meeting. Since a beneficial owner is not a shareholder of record, you may not vote those shares directly at the Meeting unless you obtain a “legal proxy” from the bank, broker or other nominee that holds your shares directly, giving you the right to vote the shares at the Meeting. Abstentions and “broker non-votes” are counted as present and entitled to vote for purposes of determining a quorum. A “broker non-vote” occurs when a bank, broker or other holder of record holding Ordinary Shares for a beneficial owner attends the Meeting but does not vote on a particular Proposal because that holder does not have discretionary voting power for that particular item and has not received instructions from the beneficial owner. Brokers that hold Ordinary Shares of the Company in “street name” for clients (as described above) typically have authority to vote on “routine” Proposals even when they have not received instructions from beneficial owners. Proposal 1 is the only item on the Meeting agenda, and we believe it is non-routine; however, we cannot be certain whether it will be treated as a routine matter since our Proxy Statement is prepared in compliance with the Companies Law, rather than the rules applicable to domestic U.S. reporting companies. Therefore, it is important for a shareholder that holds Ordinary Shares of the Company through a bank or broker to instruct its bank or broker how to vote its Ordinary Shares, if the shareholder wants its Ordinary Shares of the Company to count for Proposal 1.

 

 Sincerely,
  
 /s/ Tal Parnes
 Chairman of the Board of Directors
  
 November 20, 2026

 

 

 

 

QTREX QUANTUM LTD.

NESS-ZIONA, ISRAEL

 

PROXY STATEMENT

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

TO BE HELD ON DECEMBER 28, 2026

 

The enclosed proxy statement (the “Proxy Statement”) is being solicited by the board of directors (the “Board of Directors”) of QTREX Quantum Ltd. (the “Company”) for use at the Company’s extraordinary general meeting of shareholders (the “Meeting”) to be held on December 28, 2026, at 2:00 p.m. Israel time, or at any adjournment or postponement thereof.

 

Upon the receipt of a properly executed proxy in the form enclosed, the persons named as proxies therein shall vote the ordinary shares, no par value, of the Company (the “Ordinary Shares”) covered thereby in accordance with the directions of the shareholders executing the proxy. In the absence of such directions, and except as otherwise mentioned in this Proxy Statement, the Ordinary Shares represented thereby shall be voted in favor of Proposal 1.

 

Quorum

 

Two or more shareholders present, personally or by proxy, holding in the aggregate not less than twenty-five percent (25%) of the Company’s outstanding Ordinary Shares, shall constitute a quorum for the Meeting. If within half an hour from the time the Meeting is convened a quorum is not present, the Meeting shall stand adjourned until December 28, 2026, at 3:00 p.m. Israel time (the “Adjourned Meeting”). At the Adjourned Meeting, any number of shareholders present personally or by proxy shall be deemed a quorum and shall be entitled to deliberate and to resolve in respect of the matters for which the Meeting was convened. Abstentions and “broker non-votes” are counted as present and entitled to vote for purposes of determining a quorum (see “Beneficial Owners” in the Notice for a description of broker non-votes).

 

Required Majority

 

Pursuant to the Israeli Companies Law, 5759-1999 (the “Companies Law”), Proposal 1, as described below, requires the affirmative vote of shareholders present at the Meeting, in person or by proxy, and holding Ordinary Shares representing, in the aggregate, at least a majority of the votes cast by shareholders at the Meeting with respect to Proposal 1 (a “Simple Majority”).

 

In accordance with the Companies Law and the regulations promulgated thereunder, any shareholder of the Company holding at least 1% of the Company's outstanding voting rights for the Meeting may submit to the Company a proposed additional agenda item for the Meeting (and in case of a proposed additional agenda item for nomination or removal of a director, at least five percent (5%)) to Ms. Yafit Tehila, via e-mail (yafit@q-trex.com) no later than November 27, 2026. All such submissions must comply with the requirements under the Companies Law, the regulations promulgated thereunder, and the Current Articles.

 

Position Statements

 

Shareholders wishing to express their position on an agenda item for this Meeting may do so by submitting a written statement (a “Position Statement”) to the Company’s offices at 2 Ilan Ramon St., Ness-Ziona, 7403635, Israel. Any Position Statement received shall be furnished with the U.S. Securities and Exchange Commission (“SEC”) on a Report of Foreign Private Issuer on Form 6-K and be made available to the public on the SEC’s website at www.sec.gov. Position Statements should be submitted to the Company no later than December 14, 2026. A shareholder is entitled to contact the Company directly and receive the text of the proxy card and any Position Statement. The Board of Directors’ response to the Position Statement shall be submitted no later than December 19, 2026.

 

It is noted that there may be changes on the agenda after publishing the Proxy Statement, including Position Statements. Therefore, the most updated agenda shall be furnished with the SEC on a Report of Foreign Private Issuer on Form 6-K and shall be made available to the public on the SEC’s website at www.sec.gov.

 

2

 

 

PROPOSAL 1

 

TO APPROVE THE ISSUANCE OF THE COMPANY’S ORDINARY SHARES UNDERLYING THE PENNY WARRANTS AND ADDITIONAL WARRANTS, AS DEFINED IN THE ACCOMPANYING PROXY STATEMENT, UPON EXERCISE THEREOF, AS PART OF THE CONSIDERATION OF THE SHARE AND INTERCOMPANY DEBT PURCHASE AGREEMENT BETWEEN THE COMPANY AND NANO DIMENSION LTD., TO ACQUIRE ALL OF THE ISSUED AND OUTSTANDING SHARES OF GLOBAL INKJET SYSTEMS LIMITED 

 

Background

 

Under Nasdaq Listing Rule 5635(d), shareholder approval is required before the issuance of securities in a private placement if the transaction involves the sale, issuance or potential issuance of common stock or securities convertible into or exercisable for common stock equal to 20% or more of the common stock or voting power outstanding before the issuance, at a price below the minimum price, as defined in the Nasdaq rules.

 

The Acquisition and the Consideration Securities 

On November 16, 2026 (the “Issue Date” and “Closing Date”), the Company entered into and consummated the share and intercompany debt purchase agreement (the “Agreement”) with Nano Dimension Ltd. (“Nano”), pursuant to which the Company acquired all of the issued and outstanding shares of Global Inkjet Systems Limited (“GIS”) and the rights to the transaction intercompany debt and any other intercompany debt transferred under the Agreement (collectively, the “Acquisition”).

 

The consideration paid by the Company for the Acquisition entirely in securities of the Company and subject to the adjustments set forth in the Agreement. The securities issued or issuable in connection with the Acquisition include: (i) 3,551,693 Ordinary Shares; (ii) pre-funded warrants exercisable to purchase up to 10,130,977 Ordinary Shares with an exercise price of $0.0001 per Ordinary Share (the “Pre-Funded Warrants”); (iii) a separate holdback pre-funded warrant exercisable to purchase up to 545,455 Ordinary Shares with an exercise price of $0.0001 per Ordinary Share; (iv) penny warrants exercisable to purchase up to 317,329 Ordinary Shares with an exercise price of $0.0001 per Ordinary Share (the “Penny Warrants”); and (v) additional warrants exercisable to purchase up to 10,909,091 Ordinary Shares with an exercise price of $1.21 per Ordinary Share (the “Additional Warrants” and together with the Penny Warrants, the “Warrants”). The base consideration, which does not include the Additional Warrants, was valued at US$16 million, based on a price of $1.10 per Ordinary Share, subject to adjustment.

 

The Company is seeking shareholder approval for the issuance of the Warrants, which reflect part of the consideration for the Acquisition.

 

Proposed Terms of the Penny Warrants and Additional Warrants

 

On the Closing Date, the Company issued Penny Warrants that are exercisable to purchase up to 317,329 Ordinary Shares, subject to the receipt of shareholder approval. Its aggregate exercise price was prepaid, except for a remaining nominal exercise price of $0.0001 per Ordinary Share, and it may be exercised on a cashless basis. If shareholder approval for the exercise of the Penny Warrants is not obtained by the 90th day following the issuance date of the Penny Warrants (the “End Date”), Nano may, in its sole discretion, require (the “Redemption Notice”, and “Redemption Option”, respectively) the Company to redeem the Penny Warrant in its entirety for $349,061.90 in cash, payable within three trading days after the Company receives a Redemption Notice.

 

In addition, on the Closing Date, the Company issued the Additional Warrants that are exercisable to purchase up to 10,909,091 Ordinary Share, at an exercise price of $1.21 per Ordinary Share, subject to the receipt of shareholder approval. The Additional Warrants expire on the earliest of (i) the closing of the Redemption Option, (ii) the second anniversary of the date Shareholder Approval is obtained, and (iii) the second anniversary of the End Date. If Shareholder Approval is not obtained by the End Date, Nano may, in its sole discretion, require the Company to redeem the entirety of the Additional Warrants for $1,000,000 in cash, payable within three trading days after the Company receives Nano’s Redemption Notice.

 

The Agreement also requires the Company to use its best efforts to file a resale registration statement within 21 days after Closing Date.

 

The Warrants also provide for adjustments to the exercise price and/or the number of Ordinary Shares underlying the Warrants in connection with share dividends, share splits, rights offerings, distributions, reorganizations and similar events.

 

Pursuant to the Agreement, the Company is required to hold a shareholders’ meeting to seek shareholder approval for the issuance of Ordinary Shares underlying the Penny Warrants and the Additional Warrants upon exercise thereof, as promptly as practicable after the Closing Date and, in any event, no later than 45 days after Closing. If the required shareholder approval is not obtained at that meeting, the Company is required to hold another shareholders’ meeting no later than 90 days after the date of the Agreement and, in connection with that meeting, to engage a proxy solicitor. If the required shareholder approval is not obtained by that deadline, the Company is required to continue holding shareholders’ meetings every 45 days thereafter until the required shareholder approval is obtained or the Penny Warrants and the Additional Warrants are terminated.

 

3

 

 

Board’s Recommendation

 

The Board believes that the Acquisition of GIS brings key production controls in-house and expands the Company’s capacity to manufacture cryogenic interconnects at commercial scale. GIS’s hardware, software and fluid-delivery systems support the materials-deposition process used in the Company’s additively manufactured electronics production. The Board expects that the Company will use GIS’s capabilities to increase production throughput, improve consistency in the radio-frequency performance of its cryogenic interconnects, and develop additional interconnect materials and embedded passive components. The Board also believes that the Acquisition will support the Company’s anticipated commercial opportunities in quantum computing. GIS is expected to continue operating from its Cambridge facility, where its engineering team develops products and supports existing customers.

 

In making its decision to approve the issuance of Penny Warrants and Additional Warrants as part of the consideration of the Acquisition, and recommend that the Company’s shareholders approve the same, the Board considered, among other things: (i) the strategic fit between GIS’s printhead control, software and fluid-delivery capabilities and the Company’s plans to scale production of cryogenic interconnects; (ii) the opportunity to bring key production capabilities, an experienced engineering team, technology and intellectual property in-house; (iii) the potential to accelerate the development of larger, multi-head production systems, increase production throughput and improve consistency in the performance of the Company’s products; (iv) the opportunity to develop additional interconnect materials and support the Company’s anticipated commercial opportunities in quantum computing; and (v) the time, cost and execution risks of developing comparable capabilities internally. The Board also considered the Company’s review of GIS’s business, operations and financial forecasts, and the valuation analysis presented to it. Based on these considerations, the Board determined that the Transaction is in the best interests of the Company and its shareholders and recommends that the shareholders approve the proposed issuance.

 

The shareholders of the Company are requested to adopt the following resolution:

 

“RESOLVED, to approve the issuance of the Company’s Ordinary Shares underlying the Penny Warrants and the Additional Warrants, upon exercise thereof, as part of the consideration of the Agreement between the Company and Nano, to acquire all of the issued and outstanding shares of GIS, as set forth in the Proxy Statement.”

 

The approval of Proposal 1 requires the affirmative vote of a Simple Majority, as defined in this Proxy Statement.

 

The Board of Directors unanimously recommends a vote FOR the above proposal.

 

4

 

 

Your vote is important! Shareholders are urged to complete and return their proxies promptly in order to, among other things, ensure action by a quorum and to avoid the expense of additional solicitation. If the accompanying proxy is properly executed and returned in time for voting, and a choice is specified, the shares represented thereby shall be voted as indicated thereon. EXCEPT AS MENTIONED OTHERWISE IN THIS PROXY STATEMENT, IF NO SPECIFICATION IS MADE, THE PROXY SHALL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS DESCRIBED IN THIS PROXY STATEMENT.

 

Proxies and all other applicable materials should be sent to:

 

Equinity Trust Company, LLC

6201 15th Avenue

Brooklyn, NY 11219

 

ADDITIONAL INFORMATION

 

The Company is subject to the informational requirements of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), as applicable to foreign private issuers. Accordingly, the Company files reports and other information with the SEC. All documents which the Company will file on the SEC’s EDGAR system will be available for retrieval on the SEC’s website at http://www.sec.gov.

 

As a foreign private issuer, the Company is exempt from the rules under the Exchange Act prescribing certain disclosure and procedural requirements for proxy solicitations. In addition, the Company is not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as United States companies whose securities are registered under the Exchange Act. The Notice of the Extraordinary General Meeting of Shareholders and the proxy statement have been prepared in accordance with applicable disclosure requirements in the State of Israel.

 

YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROXY STATEMENT OR THE INFORMATION FURNISHED TO YOU IN CONNECTION WITH THIS PROXY STATEMENT WHEN VOTING ON THE MATTERS SUBMITTED TO SHAREHOLDER APPROVAL HEREUNDER. THE COMPANY HAS NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION THAT IS DIFFERENT FROM WHAT IS CONTAINED IN THIS DOCUMENT. THIS PROXY STATEMENT IS DATED NOVEMBER 20, 2026. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS DOCUMENT IS ACCURATE AS OF ANY DATE OTHER THAN NOVEMBER 20, 2026, AND THE MAILING OF THIS DOCUMENT TO SHAREHOLDERS SHOULD NOT CREATE ANY IMPLICATION TO THE CONTRARY.

 

 By Order of the Board of Directors
 QTREX Quantum Ltd.
  
 /s/ Tal Parnes
 Chairman of the Board of Directors
  
 November 20, 2026

 

*        *        *

5

 

 

QTREX QUANTUM LTD.

PROXY

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

 

The undersigned hereby appoints, Yafit Tehila, Chief Financial Officer of QTREX Quantum Ltd. (the “Company”) and Dagi Ben-Noon, Chief Executive Officer of the Company, and each of them, agents and proxies of the undersigned, with full power of substitution to each of them, to represent and to vote on behalf of the undersigned all the Ordinary Shares of the Company which the undersigned is entitled to vote at the Extraordinary General Meeting of Shareholders (the “Meeting”) to be held on December 28, 2026 at 2:00 p.m. Israel time, and at any adjournments or postponements thereof, upon the following matters, which are more fully described in the Notice of Extraordinary General Meeting of Shareholders and proxy statement relating to the Meeting.

 

This Proxy, when properly executed, shall be voted in the manner directed herein by the undersigned. If no direction is made with respect to any matter, this Proxy shall be voted FOR such matter. Any and all proxies heretofore given by the undersigned are hereby revoked.

 

(Continued and to be signed on the reverse side)

 

6

 

 

QTREX QUANTUM LTD.

EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

 

Date of Meeting: December 28, 2026

 

PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE
MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE ☒

 

1.To approve the issuance of the Company’s Ordinary Shares underlying the Penny Warrants and the Additional Warrants, upon exercise thereof, as part of the consideration of the Agreement between the Company and Nano, to acquire all of the issued and outstanding shares of GIS, as set forth in the Proxy Statement.

 

 ☐FOR☐AGAINST☐ABSTAIN

 

In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the Meeting or any adjournment or postponement thereof.

 

     
NAME SIGNATURE DATE
     
     
NAME SIGNATURE DATE

 

Please sign exactly as your name appears on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, trustee or guardian, please give full title as such. If the signed is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

 

7

Filing Exhibits & Attachments

1 document

Keep reading